Involvement of L-arginine-nitric oxide pathway in cerebral vasospasm
L-精氨酸-一氧化氮途径参与脑血管痉挛
基本信息
- 批准号:05454396
- 负责人:
- 金额:$ 4.42万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Although cerebral vasospasm is one of the major complications after subarachnoid hemorrhage, its pathogenesis remains to be elucidated. Cerebral circulation is regulated by vasoactive substances released from vasoactive substances such as EDRF (i.e.NO) , endothelin, and also by neurotransmitters from perivascular nerve fibers such as CGRP,VIP,SP,NO.We investigated in the present study the possible involvement of NO in the occurrence of cerebral vasospasm after subarachnoid hemorrhage. Experimental subarachnoid hemorrhage was produced in rats and dogs by injecting autologous arterial blood into the cistema magna.Severe vasospasm was obtained in basilar arteries on Day 1 in rats and Day 3 in dogs. Immunopositive materials for NO synthase in the endothelium and in the adventitial nerve fibers of major cerebral arteries were reduced after subarachnoid hemorrhage, and NO mediated endothelium dependent vasorelaxations and NO mediated neurogenic vasorelaxations were impaired after subarachnoid hemorrhage. These results indicated that the impairement of NO mediated vasorelaxation mechanisms might be involved in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage.
脑血管痉挛是蛛网膜下腔出血后的主要并发症之一,其发病机制尚不清楚。脑循环受EDRF(即NO)、内皮素等血管活性物质释放的血管活性物质以及血管周围神经纤维的CGRP、VIP、SP、NO等神经递质的调节。用自体动脉血注入枕大池造成大鼠和狗实验性蛛网膜下腔出血,大鼠第1天和狗第3天基底动脉出现严重的血管痉挛。蛛网膜下腔出血后,主要脑动脉内皮和外膜神经纤维中NO合酶的免疫阳性物质减少,并且NO介导的内皮依赖性血管舒张和NO介导的神经源性血管舒张在蛛网膜下腔出血后受损。提示NO介导的血管舒张机制受损可能参与了蛛网膜下腔出血后脑血管痉挛的发病机制。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
野崎 和彦: "脳血管壁NO合成酵素(NOS)含有神経線維" スパズムシンポ講演集,脳血管攣縮. 9. 16-23 (1993)
Kazuhiko Nozaki:“脑血管壁含 NO 合酶 (NOS) 的神经纤维”痉挛研讨会讲座,脑血管痉挛。 9. 16-23 (1993)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kazuhiko Nozaki: "Pathogenesis of Cerebral Vasospasm" Neurosurgery Letters. Vol 3. 647-652 (1993)
野崎和彦:“脑血管痉挛的发病机制”神经外科快报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
野崎和彦: "脳血管壁NO合成酵素(NOS)含有神経線維-くも膜下出血後の変化について-" スパズムシンポ講演集. 9. (1993)
野崎和彦:“脑血管壁含 NOS 的神经纤维 - 蛛网膜下腔出血后的变化”痉挛研讨会讲座 9。(1993 年)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
野崎和彦: "脳血管壁NO合成酵素(NOS)含有神経線維" スパズムシンポ講演集,脳血管攣縮. 9. 16-23 (1993)
Kazuhiko Nozaki:“脑血管壁含 NO 合酶 (NOS) 的神经纤维”痉挛研讨会讲座,脑血管痉挛。 9. 16-23 (1993)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
野崎和彦: "脳循環調節におけるNOの役割" 血管. 17. 39-44 (1994)
Kazuhiko Nozaki:“NO 在脑循环调节中的作用”血管。 17. 39-44 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIKUCHI Haruhiko其他文献
KIKUCHI Haruhiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIKUCHI Haruhiko', 18)}}的其他基金
Attempts to immortalize vascular smooth muscle cells for the elucidation of the pathogenesis of moyamoya disease
尝试使血管平滑肌细胞永生化以阐明烟雾病的发病机制
- 批准号:
07457314 - 财政年份:1995
- 资助金额:
$ 4.42万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Non-invasive vagus nerve stimulation to mitigate subarachnoid hemorrhage induced inflammation
无创迷走神经刺激减轻蛛网膜下腔出血引起的炎症
- 批准号:
10665166 - 财政年份:2023
- 资助金额:
$ 4.42万 - 项目类别:
Role of a novel hypothalamic protein SRPX2 in hypothalamic injury after subarachnoid hemorrhage
新型下丘脑蛋白SRPX2在蛛网膜下腔出血后下丘脑损伤中的作用
- 批准号:
23K15671 - 财政年份:2023
- 资助金额:
$ 4.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Nimodipine Systemic Exposure and Outcomes Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Multi-centre Observational Study (ASH-II Study)
尼莫地平全身暴露和动脉瘤性蛛网膜下腔出血后的结果:一项前瞻性多中心观察研究(ASH-II 研究)
- 批准号:
494000 - 财政年份:2023
- 资助金额:
$ 4.42万 - 项目类别:
Operating Grants
Electroencephalographic signatures of dysfunctional cerebrovascular autoregulation as biomarkers of brain injury in aneurysmal subarachnoid hemorrhage (SAH)
脑血管自动调节功能障碍的脑电图特征作为动脉瘤性蛛网膜下腔出血(SAH)脑损伤的生物标志物
- 批准号:
10667162 - 财政年份:2023
- 资助金额:
$ 4.42万 - 项目类别:
Development of a 3D neurovascular unit for in vitro modeling of subarachnoid hemorrhage and screening therapies
开发用于蛛网膜下腔出血体外建模和筛选治疗的 3D 神经血管单元
- 批准号:
10722387 - 财政年份:2023
- 资助金额:
$ 4.42万 - 项目类别:
Development of novel drugs for subarachnoid hemorrhage focusing on ferroptosis
以铁死亡为重点的蛛网膜下腔出血新药开发
- 批准号:
23K15661 - 财政年份:2023
- 资助金额:
$ 4.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Roles of NAMPT and NAD+ in hypoxic conditioning-induced neurovascular protection in subarachnoid hemorrhage
NAMPT和NAD在蛛网膜下腔出血低氧条件诱导的神经血管保护中的作用
- 批准号:
10660398 - 财政年份:2023
- 资助金额:
$ 4.42万 - 项目类别:
GPR39 as a Therapeutic Target in Subarachnoid Hemorrhage (SAH)
GPR39 作为蛛网膜下腔出血 (SAH) 的治疗靶点
- 批准号:
10478533 - 财政年份:2022
- 资助金额:
$ 4.42万 - 项目类别:
A Novel Targeted Therapy for Subarachnoid Hemorrhage
蛛网膜下腔出血的新型靶向治疗
- 批准号:
10385590 - 财政年份:2022
- 资助金额:
$ 4.42万 - 项目类别:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
使用去铁酮改善蛛网膜下腔出血的认知结果:U-DISCO
- 批准号:
10677785 - 财政年份:2022
- 资助金额:
$ 4.42万 - 项目类别: